Aurobindo Pharma Ltd (AUROPHARMA) — promoter pledge

Pledged promoter shares first appear in Aurobindo Pharma Ltd's Sep 2010 filing, covering 21.4% of promoter holding. The share of promoter holding pledged peaked at 23.6% (12.3% of total equity), most recently in Mar 2026, against 13.8% in Jun 2026. A year earlier, in Jun 2025, the figure was 17.1%. A pledge is reported in 64 of the 85 quarters of promoter shareholding data Solomo holds for this company.

7 members of the promoter group report pledged shares in Jun 2026: RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING) (33.54% of the company, 14.1% of it pledged), KAMBAM NITHYANANDA REDDY (4.37% of the company, 38.4% of it pledged), KIRTHI REDDY KAMBAM (3.46% of the company, 13.6% of it pledged) and 4 others.

Ranked by share of promoter holding pledged, Aurobindo Pharma Ltd is #316 of the 563 listed Indian companies whose latest quarterly filing reports any pledged promoter shares.

A promoter pledge means a promoter has put their own shares up as collateral, usually against a loan. It is legal and common, and SEBI requires it to be disclosed every quarter in the shareholding pattern. It matters to other shareholders because a sharp fall in the share price can trigger a margin call: if the promoter cannot top up the collateral, the lender can invoke the pledge and sell those shares in the open market, which adds selling pressure to an already falling price and, at high pledge levels, can change who controls the company. The percentage on its own is not a verdict — the level, the direction of travel and what the borrowing funded all matter.